The drug gained attention when early reports suggested it might benefit COVID-19 patients
On March 20, the Food and Drug Administration (FDA) issued an emergency use
You may not feel any different at first, but it is likely to be working
It's also an antimalarial medication used to prevent and treat malaria in adults and children
It is hoped that one or more of the treatments under trial will result in improving clinical outcomes in COVID-19 patients and save lives
swelling of the eye
However, long-term hydroxychloroquine usage was linked to a higher risk of cardiovascular death (HR 1
Some diseases treated with Plaquenil are: Lupus, which causes fever, rashes, skin problems, and other symptoms
It works by blocking the effects of the chemicals released when your immune system attacks your body
Hydroxychloroquine may cause some people to be agitated, irritable, or display other abnormal behaviors within the first month after the start of treatment
Hydroxychloroquine is generally safe at normal doses, but higher amounts can damage the retina, the light-sensitive tissue at the back of the eye, and could result in partial or complete blindness
Hydroxychloroquine is a derivative of chloroquine that has both antimalarial and antiinflammatory activities and is now most often used as an antirheumatologic agent in systemic lupus erythematosis and rheumatoid arthritis